Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentinel Node Policy vs Current Staging in Early Stage Endometrial Carcinomas
NCT02598219Phase 3Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Nov 2015
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in endometrial carcinoma (2 arms), sponsored by Centre Oscar Lambret. Primary endpoint: Morbidity at 3 months. Started Nov 2015; status: completed.
02
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT02598219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598219.